Académique Documents
Professionnel Documents
Culture Documents
13-Feb-17
Top News
GAIL concall update: IPCA Lab concall update:
Prices have been lower in all segment particularly petchem. UK business is impacted by approx 15% on account of Brexit . Revenue
Lower realization in polymer in Q3FY17. from UK business in 9M FY17 is Rs.258 Cr.
Capex guidance for FY18 is Rs. 3200 Cr. R&D expenses for last quarter is 4% of Sales in Q3FY17. Management
Jadgish-Haldia pipeline capex is approx Rs. 200 Cr in FY17. has guided for 4.7-5% R&D exp. In Q4FY17.
Ratangiri LNG cargoes shipment started from Nov. 2016 and will Planned Capex for FY17 & FY18 is Rs. 200-250 Cr each.
continue till May 2017. Till Dec 2016, 13 cargoes were shipped Company is in MAT tax rate.
and expected to ship 2-3 cargoes more in FY17. Deferred sales tax of Rs. 24 Cr in FY17 and scheduled Rs. 7 Cr re-
Kochi-Mangalore pipeline construction is on track. Issues in 2 payment for every year.
districts on contruction work has now been resolved upto a Remediation process at API manufacturing facility, expected to be
great extent. completed by June-July 2017.
Petrochemicals pata plant achieves capacity utilization of 80% in 8-10 filings were expected in FY18.
Q3FY17. Management has not re-invited USFDA for re-inspection at its Ratlam
LPG transmission volume are sustainable for long-term. facility. Expected to re-invite by end of FY17.
Operating cost in petrochemicals segment has declined due to Escorts Mgt Guideline : Government impetus on construction
economies of scale and management expects to bring it down equipment, railways and agriculture in the Budget will keep Escorts '
further. growth trajectory going for the next 2-3 years. Company expects 8-10
percent growth in the tractors segment in FY18. company expects
double-digit growth in tractor industry to continue. Construction
business margins, however, might remain under pressure due to
Power Grid Corp is expecting a capex target of Rs 25,000
inflation
crore for fiscal year 2017-18, after it posted a stable set of
earnings for the third quarter of FY17. Lupin eyes launch of 25 products in the US next fiscal . Company focus
The company had capitalised Rs 6,800 crore in Q3FY17 and has remains on the speciality drugs business in the US . Company launched
infused Rs 4,700 crore in Q4FY17 so far. The company has four products in the US market during the third quarter ended
achieved Rs 18,200 crore of total capex target of Rs 23,500 December 31. It received 11 approvals from the USFDA during the
crore for FY17 period.
Life Insurance Corporation of India (LIC) has acquired an ONGC's USD 2.475 billion purchase of Videocon Group's 10 per cent
additional 2 percent stake in Infosys in over three years ending stake in a giant Mozambique gas field has come under the Oil Ministry's
February 2017 taking its total shareholding to 7.02 percent scanner following allegations that the PSU may have overpaid about
USD 200 million, charges that the company vehemently denied.
TRADING IDEAS
Economic Calendar
Monday Tuesday Wednesday Thursday Friday
Country
13th Feb 17 14th Feb 17 15th Feb 17 16th Feb 17 17th Feb 17
Risk Disclosure & Disclaimer: This report/message is for the personal information of
the authorized recipient and does not construe to be any investment, legal or taxation
advice to you. Narnolia Securities Ltd. (Hereinafter referred as NSL) is not soliciting any
action based upon it. This report/message is not for public distribution and has been
furnished to you solely for your information and should not be reproduced or
redistributed to any other person in any from. The report/message is based upon publicly
available information, findings of our research wing East wind & information that we
consider reliable, but we do not represent that it is accurate or complete and we do not
provide any express or implied warranty of any kind, and also these are subject to change
without notice. The recipients of this report should rely on their own investigations,
should use their own judgment for taking any investment decisions keeping in mind that
past performance is not necessarily a guide to future performance & that the the value of
any investment or income are subject to market and other risks. Further it will be safe to
assume that NSL and /or its Group or associate Companies, their Directors, affiliates
and/or employees may have interests/ positions, financial or otherwise, individually or
otherwise in the recommended/mentioned securities/mutual funds/ model funds and
other investment products which may be added or disposed including & other mentioned
in this report/message.